Pharmaceutics

Basic Information

Brief Name: PHARMACEUTICS
Impact Factor: 4.9
ISSN: 1999-4923
Research Field: MEDICAL
h-index: 32
Self-citation Rate: 12.2%
Articles per Year: 2749

SCI Index Status: Science Citation Index Expanded
Journal Website: https://www.mdpi.com/journal/pharmaceutics
Journal Introduction:

Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. Covered topics include pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. Our aim is to encourage scientists to publish their experimental results and theoretical assumptions in as much detail as possible. There is no restriction on the maximum length of the papers. The full experimental details must be provided so that the results can be reproduced. In addition, this journal presents the following unique features: Manuscripts regarding research proposals and research ideas will be particularly welcomed Computed data or files regarding the full details of the experimental procedures can be deposited as supplementary material if it is not possible to published them in the Material and Methods section, as usual We also accept manuscripts addressed to a broader audience, regarding research projects financed by public funds Subject Areas pharmaceutical formulation delivery and controlled-release systems for drugs, vaccines, and biopharmaceuticals pharmaceutical process, engineering, biotechnology, and nanotechnology devices, cells, molecular biology, and materials science related to drugs and drug delivery pharmacogenetics and pharmacogenomics biopharmaceutics nanomedicine drug targeting drug design pharmacokinetics, toxicokinetics effects of the body on drugs (absorption, distribution, metabolism, excretion) pharmacokinetic analysis pharmacodynamics physiological and biochemical effects of drugs on the body drug–receptor interactions

CiteScore

CiteScore
7.9
SJR
0.892
SNIP
1.005
Subject Rank Percentile
Pharmacology, Toxicology and PharmaceuticsPharmaceutical Science
32 / 183 82%

Journal Statistics

Issues/Year
First decision is provided to authors approximately 14.9 days after submission; acceptance to publication is undertaken in 3.4 days
Review Cycle
CHF 2900
Article Processing Fee

Submission Information

Submission Website:

https://login.mdpi.com/login

Related Articles

British Standards Institution

Other

DOI: 10.1039/AN938630734A

Food and drugs

Other

DOI: 10.1039/AN938630664B

Reviews

Other

DOI: 10.1039/AN939640461B

Ministry of Food.—statutory rules and orders

Other

DOI: 10.1039/AN942670098B

Front matter

Other

DOI: 10.1039/AN94368FP011

Notes from the Reports of Public Analysts

Other

DOI: 10.1039/AN940650221A

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.